Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home

BiotechReality - Information Intelligence System for Biopharma

  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Phase 3 Trials #Cancer #Novo Nordisk
Cell Biology News

Mitochondria’s role in the processing of dietary fat – Research

  • By Editor's Desk
  • 28 December 2023
mitochondria research

This discovery marks a significant leap forward in understanding the crucial role of mitochondria in dietary lipid transport and metabolism.

Tagged mitochondria
News Diseases

JN.1 New COVID-19 variant: Spreading rapidly

  • By Editor's Desk
  • 23 December 2023
new covid variant
JN.1 New Covid-19 variant: Spreading rapidly

CDC says that there is no current risk to the health from the spreading variants

Tagged COVID Variant, COVID19
Molecular Biology News

Reprogramming of cell’s genetic information makes way for future cells

  • By Journal Updates
  • 22 December 2023
detection of epilepsy

The precise times at which certain sections of our genetic code are replicated are called DNA replication timing or RT.

Tagged DNA Replication
Artificial Intelligence News

A new class of antibiotic candidates were identified using AI – Research

  • By Journal Updates
  • 21 December 2023
antibiotic resistant bacteria

Researchers demonstrated that these substances could eradicate methicillin-resistant Staphylococcus aureus.

Tagged Antibiotics, Artificial Intelligence
Research News

Morning sickness in pregnant women is caused by a protein (GDF15) – Research

  • By Editor's Desk
  • 18 December 2023
gdf15
Morning sickness in pregnant women is caused by a protein (GDF15) - Research

The fetus’s hormone, GDF15, is the cause. It is a protein causes morning sickness in pregnant women.

Tagged GDF15, Morning Sickness in Pennants
Biotechnology Healthcare & Pharmaceuticals News

Harmful immune responses can be prevented by redesigning future mRNA-based therapeutics – Research

  • By Editor's Desk
  • 17 December 2023
RNA structure
Harmful immune responses can be prevented by redesigning future mRNA-based therapies; Research

mRNA vaccines are thought to be revolutionary. In addition to being utilized to combat the COVID-19 pandemic, they are also being considered for the treatment of several malignancies

Tagged mRNA, mRNA Vaccine
Genetics News

One letter difference in the DNA can generate an immune response

  • By Journal Updates
  • 16 December 2023
ai dna

Non-coding RNA drives inflammatory process regulated by interleukin

Biotechnology Immunology News

Molecular map of the human immune response created using next-gen CRISPR tool

  • By Journal Updates
  • 14 December 2023
Crispr technology
Molecular map of the human immune response created using next-gen CRISPR tool

Senior Investigator Alex Marson, MD, PhD, delved deeply into T-cell DNA to identify certain nucleotides, which are fundamental building blocks of genetic information

Tagged CRISPR, Immune Response
Science Biotechnology

Osmosis – Definition, Diagram, Applications and FAQ

  • By Achuth B S
  • 12 December 2023
osmosis diagram
Osmosis - Definition, Diagram, Applications and FAQ

Osmosis is fundamentally the process of water molecules moving through a semi-permeable membrane from a region of lower solute concentration to a region of higher solute concentration.

Tagged Osmosis, Osmosis FAQ
Healthcare & Pharmaceuticals News

Sickle Cell Disease: FDA approves first CRISPR gene therapies

  • By Editor's Desk
  • 10 December 2023
gene editing tool

Casgevy, one of these treatments, is the first FDA-approved medication to make use of a revolutionary form of genome editing technique

Tagged CRISPR, FDA, World's first CRISPR treatment

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Samsung Biologics Q3 2026 Results: Plant 5 Ramp-Up and Rockville Lift Revenue to KRW 1,490 Billion as 2026 Guidance Rises to 20%
Business CDMO Healthcare & Pharmaceuticals News

Samsung Biologics Q3 2026 Results: Plant 5 Ramp-Up and Rockville Lift Revenue to KRW 1,490 Billion as 2026 Guidance Rises to 20%

21 October 202622 October 2026
BiotechReality Business Intelligence Desk
Amgen and AstraZeneca Report TEZSPIRE Eosinophilic Esophagitis Phase 3 CROSSING Results
Clinical Data Healthcare & Pharmaceuticals News

Amgen and AstraZeneca Report TEZSPIRE Eosinophilic Esophagitis Phase 3 CROSSING Results

20 October 202620 October 2026
Clinical Trials & Data Desk
Merck KGaA Announces Silence Therapeutics Acquisition to Add Divesiran siRNA Therapy to Rare Disease Pipeline
Business Healthcare & Pharmaceuticals Merger & Acquisitions News

Merck KGaA Announces Silence Therapeutics Acquisition to Add Divesiran siRNA Therapy to Rare Disease Pipeline

19 October 202620 October 2026
BiotechReality Business Intelligence Desk
MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan
Clinical Data Healthcare & Pharmaceuticals News Oncology

MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan

17 October 202617 October 2026
Clinical Trials & Data Desk
Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types
Regulatory Approval Healthcare & Pharmaceuticals News Oncology

Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types

16 October 202617 October 2026
Clinical Trials & Data Desk
Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year
Clinical Data Healthcare & Pharmaceuticals News

Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year

15 October 202615 October 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Rare Disease Medical Science Liaison (MSL) – Amgen, Japan
    20 October 2026
  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026
  • Commercial Product Manager – Centrifuge – ThermoFisher, Singapore & Malaysia
    7 October 2026
  • Regulatory Affairs Specialist – Lonza, Hyderabad
    4 October 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter